Citi lowered the firm’s price target on Clorox (CLX) to $130 from $135 and keeps a Neutral rating on the shares. The firm sees a challenging fundamental backdrop for the beverage and household and personal care group heading into the Q3 reports. It believes trends in the U.S. remain soft.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox price target lowered to $125 from $135 at BofA
- Clorox price target lowered to $128 from $134 at UBS
- Clorox price target lowered to $117 from $120 at TD Cowen
- Clorox price target lowered to $112 from $118 at Barclays
- Clorox’s Financial Challenges and Operational Disruptions Lead to Hold Rating